[9] [12] Patients currently taking Mounjaro should contact their GP if they experience: Severe, persistent abdominal pain that may radiate to the back Persistent vomiting preventing fluid intake Signs of dehydration (reduced urination, dizziness, dark urine) Symptoms of hypoglycaemia when used with insulin or sulphonylureas Patients should report any suspected side effects to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Two analysts said this could be reflective of disease prevalence rather than gender bias
They are typically safe and effective
Oct 2: Adults and kids nine and older with primary hyperoxaluria type 1 (PH1)a rare genetic diseasehave a new treatment option after the FDA approved Novo Nordisks Rivfloza
Structured history: timing, GI symptoms/dehydration, menopause/GSM risk, meds incl
The Competitor Landscape: Eli Lilly and Company is also playing aggressively, having partnered with Cipla for its weight-loss drug Mounjaro, which has already clocked an impressive 713 crore in cumulative sales since its launch in March of last year
00217-5/asset/1d7305c6-2436-491d-bc41-6b556b89646a/main.assets/gr1.jpg)
